Prevalence of polycystic ovary syndrome in adolescents
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective To investigate the prevalence of polycystic ovary syndrome (PCOS) in adolescents and its association with obesity. Design Cross-sectional study using electronic medical records. Setting Integrated health care delivery system in Southern California. Patients Adolescents aged 15–19 years (n= 137,502). Interventions None. Main Outcome Measures PCOS diagnosed or defined according to NIH criteria. Results The prevalence of a confirmed diagnosis of PCOS was 0.56%, and increased to 1.14% when undiagnosed cases with documented symptoms qualifying for PCOS according to NIH criteria were included. Compared to normal/underweight girls, the ORs (95% CI) for confirmed PCOS diagnosis were 3.85 (3.04–4.88), 10.25 (8.16–12.84) and 23.10 (18.66–28.61) for overweight, moderately obese, and extremely obese adolescents, respectively (P-trend<0.001) after adjusting for potential confounders. When adolescents with two or more supportive diagnoses were included (diagnosed and undiagnosed PCOS-NIH) the ORs (95% CI) for PCOS-NIH by weight class were significantly attenuated to 2.95 (2.53–3.44), 6.73 (5.78–7.83), and 14.65 (12.73–16.86) for overweight, moderately obese, and extremely obese adolescents, respectively. Conclusions Overweight and obesity were associated with higher odds of PCOS in adolescents. Studies based solely on diagnosis codes may underestimate the prevalence of PCOS and overestimate the magnitude of the association between obesity and PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 1×
“Abdominal visceral adipose tissue has been identified as a better marker of metabolic health than body weight (30) and mouse models of PCOS suggest that adipose tissue and tissue-specific inflammation play a crucial role in the development of PCOS (31).”
BackgroundMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · cited 1×
“There is sufficient evidence that excessive body weight amplifies the clinical severity of PCOS and increases the risk of several metabolic and cardiovascular complications associated with PCOS, such as insulin resistance, hyperlipidemia, hypertension, and subclinical atherosclerosis (9).”
BackgroundPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Flegal, K. M., Wei, R., Ogden, C. L., Freedman, D. S., Johnson, C. L., & Curtin, L. R. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28335 · Cited by 435
Glueck, C. J., Morrison, J. A., Friedman, L. A., Goldenberg, N., Stroop, D. M., & Wang, P. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.003 · Cited by 65 · cited 1×
“Findings from some small clinical studies suggest that the metabolic risk associated with PCOS is mostly due to obesity and that PCOS does not independently increase the metabolic risk of adolescents (28, 29).”
BackgroundSmith, N., Iyer, R. L., Langer-Gould, A., Getahun, D. T., Strickland, D., Jacobsen, S. J., Chen, W., Derose, S. F., & Koebnick, C. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-316 · Cited by 62 · cited 1×
“The specificity and positive predictive values were >98% for all races/ethnicities (24).”
BackgroundSelf-citation
Cited by
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
“The prevalence of PCOS is significantly higher in adolescent girls with obesity compared with adolescent girls without overweight/ obesity (208), but the prevalence in”
BackgroundAdolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Qu, X., & Donnelly, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218191 · Cited by 210
“The manifestations of PCOS often begin during adolescence [87], suggesting that puberty/adolescence is a critical developmental stage during which the pathophysiology of PCOS unfolds.”
BackgroundMetformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis
Al Khalifah, R. A., Florez, I. D., Dennis, B., Thabane, L., & Bassilious, E. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4089 · Cited by 91
Metadata
- Authors
- Christensen, S. B., Black, M. H., Smith, N., Martinez, M. M., Jacobsen, S. J., Porter, A. H., & Koebnick, C.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 100
- Issue
- 2
- Pages
- 470-477
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1976569393
- Cited by
- 169
- References
- 7
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.